The Drug Enforcement Administration increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in the United States. What do you think?
“I don’t think the U.S. has the infrastructure to support that many focused people at once.”
Halee Browne, Gerbil Socializer
“I always knew the solution was more drugs.”
Tyler Gooden, Corporate Skeptic
“The DEA always knows where to get the good stuff.”
Jorge Reyes, Petroleum Sifter
Comments are closed.